HCPCS code J9357: Valrubicin, per 200 mg2026 Medicare rate & RVUs in Washington
J9357 reports valrubicin placed directly into the bladder, generally for persistent bladder carcinoma in situ after intravesical BCG treatment.
CMS doesn’t publish an office rate for J9357 in Washington.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J9357 covers
Valrubicin is an antineoplastic drug delivered directly into the bladder through a urinary catheter, not by intravenous infusion. Urologists use it for adults with bladder carcinoma in situ that persists or returns after intravesical BCG, particularly when cystectomy is not an appropriate option. The drug code represents the medication; CPT 51720 represents the bladder instillation service.
Each J9357 unit represents 200 mg of valrubicin, so an 800-mg administration is four units. CMS assigns physician fee schedule status E, excluding the drug from that schedule. When Medicare covers it, payment is made through another method. HCPCS classifies it as a Part B drug generally paid using CMS quarterly ASP drug pricing files when covered. Its CMS coverage code indicates that special Medicare coverage instructions apply.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J9357 pays more and less in Washington
| Payment locality | Office | Facility |
|---|---|---|
| King County, WA | Unavailable | Unavailable |
| Rest of Washington | Unavailable | Unavailable |
How the J9357 rate is calculated
Each of J9357’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J9357
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J9357
J9357 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J9357
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J9357 isn’t priced in this setting.
J9357 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- 51720Bladder instillationAntineoplastic agent
- 51720 represents the bladder instillation service; J9357 represents the valrubicin drug and its administered amount.
- J9030Intravesical BCGPer 1 mg
- J9030 identifies intravesical BCG, not valrubicin. The drugs have different roles in bladder cancer treatment.
- J9201Gemcitabine injectionPer 200 mg
- J9201 identifies gemcitabine, not valrubicin. Select the drug code that matches the medication administered.
J9357 billing questions
How many J9357 units represent an 800-mg dose?
Each unit represents 200 mg, so 800 mg is four units. Base the reported units on the amount administered.
Does J9357 represent the bladder instillation procedure?
No. J9357 represents the valrubicin drug. CPT 51720 represents bladder instillation of an anticarcinogenic agent.
How does Medicare classify payment for J9357?
CMS assigns status E, excluding J9357 from the physician fee schedule. When covered, Medicare pays through another method; HCPCS classifies it as a Part B drug generally paid using quarterly ASP drug pricing files.
What documentation supports the J9357 units?
Record the valrubicin amount administered and its intravesical route so the reported units reflect the administered dose.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J9357 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist